Archive of the journal «Russian otorhinolaryngology» - Medical scientific journal «Russian otorhinolaryngology»

Medical Scientific Journal
Russian
Otorhinolaryngology
9, Bronnitskaya Str., Saint Petersburg, 190013, Russia
Tel./Fax: (921) 922-36-77, e-mail: text@pfco.ru
 ISSN 2413-4309 (online), ISSN 1810-4800 (print)  
Rossiiskaya otorinolaringologiya
Go to content
◄◄   |   
  |    ►►
Section: Section Science articles
Combination treatments of patients with chronic rhinosinusitis with nasal polyps
I. A. Dyukova (1), A. P. Yastremskii (2), A. V. Volodeev (1), (2)
(1) Medical and Sanitary Unit „Neftyanik“, Tyumen, 625062, Russian Federation, (2) Tyumen State Medical University, Tyumen, 625023, Russian Federation
UDK: УДК 616.211-002.2-006.5- 08-059:615.37

DOI: https://doi.org/10.18692/1810-4800-2024-2-25-30

ABSTRACT
Targeted therapy has changed the approach to the management of patients with chronic rhinosinusitis with nasal polyps (CRwNP) type 2. However, the treatment of such patients remains one of the urgent problems in otorhinolaryngology, and the search for the optimal combination of treatment methods continues. Objective. To evaluate the effectiveness of combined treatment of patients with CRwNP. Material and methods. 50 patients with CRwNP were treated with dupilumab and mometasone furoate. Patients of the main group underwent endoscopic nasal polypectomy before using these drugs. The results of computed tomography of the paranasal sinuses (Lund-Mackay score and SNOT22 (Sino-Nasal Outcome Test)) were analyzed. Results. A significant decrease in the average SNOT-22 values was revealed in patients of the main group even before the start of dupilumab injections, in subjects from the comparison group, after 8 weeks. The average values on the Lund-Mackay score in patients of the main group were 21.3±2.5 and 7.0±1.1, in the comparison group, 20±2.2 and 7.5±1.3 before and after 6 months of treatment, respectively. Conclusions. Nasal polypectomy before the start of targeted therapy in patients with CRwNP type 2 and severe nasal obstruction helps improve the quality of life according to the SNOT-22 before starting treatment with dupilumab.
Publication date:
17.04.2024
Keywords:
chronic rhinosinusitis with nasal polyps, nasal polypectomy, dupilumab.
For citation:
Dyukova I. A., Yastremskii A. P., Volodeev A. V. Combination treatments of patients with chronic rhinosinusitis with nasal polyps. Russian Otorhinolaryngology. 2024;23(2):25-30. https://doi.org/10.18692/1810-4800-2024-2-25-30
All rights to this publication are registered. Link to Russian Otorhinolaryngology Journal is required.
Reprinting of both individual articles and the Journal itself without the publisher`s permission is prohibited.
The Journal editors and publisher are not liable for the content and accuracy of advertising information.
© St. Petersburg Research Institute of Ear, Throat, Nose, and Speech of the Ministry of Health of Russia
© Scientific Clinical Center of Otorhinolaryngology, FMBA of Russia
Логотип журнала "Российская оториноларингология"
© Co. Ltd. Polyforum Group, 2012—
Яндекс.Метрика
Back to content